HK1030545A1 - Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture - Google Patents

Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture

Info

Publication number: HK1030545A1
Authority: HK; Hong Kong
Prior art keywords: vertebral; hormone; parathyroide; risk; reducing
Prior art date: 1998-08-19

Application number

HK01101056A

Other languages

English (en)

Inventor

Janet M Hock

Gregory A Gaich

Willard H Dere

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-19

Filing date

2001-02-14

Publication date

2001-05-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1030545(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-02-14 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2001-05-11 Publication of HK1030545A1 publication Critical patent/HK1030545A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Steroid Compounds (AREA)
Materials For Medical Uses (AREA)

HK01101056A 1998-08-19 2001-02-14 Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture HK1030545A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US9715198P	1998-08-19	1998-08-19
US9974698P	1998-09-10	1998-09-10
PCT/US1999/018961 WO2000010596A1 (fr)	1998-08-19	1999-08-19	Procede permettant d'augmenter la solidite et la rigidite osseuse et de reduire l'incidence ou la gravite d'une fracture

Publications (1)

Publication Number	Publication Date
HK1030545A1 true HK1030545A1 (en)	2001-05-11

Family

ID=26792729

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
HK01101056A HK1030545A1 (en)	1998-08-19	2001-02-14	Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture
HK07110798.6A HK1102496A1 (en)	1998-08-19	2007-10-04	Hpth(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human
HK16100519.4A HK1212602A1 (zh)	1998-08-19	2016-01-18	增加骨的韌性和硬度和減少骨折的方法

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
HK07110798.6A HK1102496A1 (en)	1998-08-19	2007-10-04	Hpth(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human
HK16100519.4A HK1212602A1 (zh)	1998-08-19	2016-01-18	增加骨的韌性和硬度和減少骨折的方法

Country Status (33)

Country	Link
US (2)	US6977077B1 (fr)
EP (3)	EP1059933B1 (fr)
JP (5)	JP2002523375A (fr)
KR (1)	KR100454207B1 (fr)
CN (1)	CN1205997C (fr)
AR (1)	AR033639A1 (fr)
AT (1)	ATE231000T1 (fr)
AU (1)	AU746277B2 (fr)
BR (1)	BR9909445A (fr)
CA (1)	CA2325371C (fr)
CO (1)	CO5130020A1 (fr)
CY (2)	CY1113343T1 (fr)
CZ (1)	CZ301017B6 (fr)
DE (2)	DE69904918T2 (fr)
DK (4)	DK1059933T3 (fr)
DZ (1)	DZ2873A1 (fr)
EA (1)	EA003362B1 (fr)
ES (4)	ES2393200T3 (fr)
HK (3)	HK1030545A1 (fr)
HR (1)	HRP20000755A2 (fr)
HU (2)	HU1200430D0 (fr)
ID (1)	ID29039A (fr)
IL (2)	IL138829A0 (fr)
MY (1)	MY129227A (fr)
NO (2)	NO323984B1 (fr)
NZ (1)	NZ507056A (fr)
PE (1)	PE20001089A1 (fr)
PL (1)	PL201688B1 (fr)
PT (4)	PT1059933E (fr)
TR (1)	TR200003455T2 (fr)
TW (1)	TW576747B (fr)
UA (1)	UA72205C2 (fr)
WO (1)	WO2000010596A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6770623B1 (en)	1997-12-09	2004-08-03	Eli Lilly And Company	Stabilized teriparatide solutions
DZ2873A1 (fr)	1998-08-19	2003-12-15	Lilly Co Eli	Procédé pour augmenter la dureté et la rigidité osseuse.
US20040033950A1 (en) *	2000-09-26	2004-02-19	Hock Janet M.	Method of increasing bone toughness and stiffness and reducing fractures
EP1222465A1 (fr) *	1999-09-20	2002-07-17	Eli Lilly And Company	Procede remettant d'effectuer le suivi du traitement avec une hormone parathyroidienne
US7247609B2 (en)	2001-12-18	2007-07-24	Universitat Zurich	Growth factor modified protein matrices for tissue engineering
CA2472472A1 (fr)	2002-01-10	2003-07-24	Osteotrophin Llc	Traitement des affections osseuses avec des medicaments anabolisants du squelette
US8088734B2 (en)	2003-01-21	2012-01-03	Unigene Laboratories Inc.	Oral delivery of peptides
JP2007505883A (ja) *	2003-09-19	2007-03-15	ファイザー・プロダクツ・インク	２−アルキリデン−１９−ノル−ビタミンｄ誘導体及び副甲状腺ホルモンの組合せを含んでなる医薬組成物及び方法
US20060189533A1 (en) *	2004-05-10	2006-08-24	Nastech Pharmaceutical Company Inc.	Stable pharmaceutical dosage forms of teriparatide
JP2007537274A (ja) *	2004-05-10	2007-12-20	ナステックファーマスーティカルカンパニーインク．	副甲状腺ホルモンの粘膜送達を増強するための組成物及び方法
US20060052305A1 (en) *	2004-05-10	2006-03-09	Nastech Pharmaceutical Company Inc.	Method of treating osteoporosis using intranasal parathyroid hormone
US20060127320A1 (en) *	2004-05-10	2006-06-15	Nastech Pharmaceutical Company Inc.	Method of delivering parathyroid hormone to a human
EP1744683B1 (fr)	2004-05-13	2016-03-16	Alza Corporation	Appareil et procédé pour la délivrance transdermique d'agents à base d'hormone parathyroïde
US7648965B2 (en)	2004-05-14	2010-01-19	Unigene Laboratories Inc.	Method for fostering bone formation and preservation
US20060069021A1 (en) *	2004-08-13	2006-03-30	Nastech Pharmaceutical Company Inc.	Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogs
US8575101B2 (en)	2005-01-06	2013-11-05	Kuros Biosurgery Ag	Supplemented matrices for the repair of bone fractures
WO2006073711A2 (fr)	2005-01-06	2006-07-13	Kuros Biosurgery Ag	Traitement local des deficits osseux
CA2608016A1 (fr) *	2005-05-11	2006-11-23	Unigene Laboratories, Inc.	Methode visant a ameliorer la formation et la preservation des os consistant a induire chirurgicalement une augmentation de l'activite des osteoblastes couplee aux effets de l'administration de la pthrp ou du cgrp
US20070173447A1 (en) *	2005-10-25	2007-07-26	Nastech Pharmaceutical Company Inc.	Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
EP1945245A2 (fr) *	2005-11-10	2008-07-23	The Board of Control of Michigan Technological University	Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
US20080051332A1 (en) *	2005-11-18	2008-02-28	Nastech Pharmaceutical Company Inc.	Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20080119408A1 (en) *	2006-07-07	2008-05-22	Nastech Pharmaceutical Company Inc.	Pth formulations for intranasal delivery
EP1961765A1 (fr) *	2006-12-08	2008-08-27	Zealand Pharma A/S	Peptides PTH tronqués à formation cyclique
PT2136850E (pt)	2007-04-13	2012-04-27	Kuros Biosurgery Ag	Selante tecidual polimérico
US20110137243A1 (en) *	2007-09-06	2011-06-09	Abbott Cardiovascular Systems Inc.	Coating On A Balloon Device
EP2217260B1 (fr) *	2007-12-04	2016-11-09	Ben-Gurion University Of The Negev Research And Development Authority	Matrices peptidiques amphiphiles pour le traitement de l'ostéoporose
CA2710798A1 (fr)	2007-12-28	2009-07-09	Kuros Biosurgery Ag	Proteines hybrides du pdgf incorporees dans des mousses de fibrine
KR102335703B1 (ko)	2009-09-09	2021-12-07	아사히 가세이 파마 가부시키가이샤	1회당 100∼200 단위의 ｐｔｈ가 주 1회 투여되는 것을 특징으로 하는, ｐｔｈ 함유 골다공증 치료/예방제
BR112012013725A2 (pt)	2009-12-07	2017-01-10	Univ Michigan Tech	paratormônio de urso preto e métodos de usar o paratormônio de uso preto.
US9295663B2 (en)	2010-07-14	2016-03-29	Abbott Cardiovascular Systems Inc.	Drug coated balloon with in-situ formed drug containing microspheres
WO2012111852A1 (fr) *	2011-02-17	2012-08-23	帝人ファーマ株式会社	Agent thérapeutique pour fracture de corps vertébral et procédé pour évaluer celui-ci
ES2882852T3 (es)	2011-03-16	2021-12-02	Kuros Biosurgery Ag	Formulación farmacéutica para la utilización en la fusión espinal
ES2761635T3 (es)	2011-06-07	2020-05-20	Asahi Kasei Pharma Corp	Preparación liofilizada que contiene PTH de alta pureza y método para producirla
US9700485B2 (en)	2013-04-24	2017-07-11	Corning Incorporated	Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
WO2017136195A1 (fr)	2016-02-01	2017-08-10	Eli Lilly And Company	Composés de fusion parathormone-anticorps anti-rankl
US20190381341A1 (en) *	2017-02-01	2019-12-19	The Johns Hopkins University	Parathyroid hormone and regeneration of degenerative discs disease
EP3685849A4 (fr) *	2017-09-22	2021-12-22	Asahi Kasei Pharma Corporation	Composition pharmaceutique liquide contenant du tériparatide ayant une excellente stabilité
WO2020090174A1 (fr)	2018-10-29	2020-05-07	旭化成ファーマ株式会社	Méthode de prévention ou de traitement de l'ostéoporose caractérisée par l'administration de tériparatide ou d'un sel de celui-ci deux fois par semaine
EP4010360A1 (fr)	2019-08-09	2022-06-15	Flagship Pioneering Innovations VI, LLC	Modulateurs du récepteur de l'hormone parathyroïdienne (pthr1)
GB2590692A (en) *	2019-12-24	2021-07-07	Corthotec Ltd	Composition for improved bone fracture healing

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4086196A (en)	1975-03-28	1978-04-25	Armour Pharmaceutical Company	Parathyroid hormone
IL78342A (en)	1985-04-04	1991-06-10	Gen Hospital Corp	Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
DE3935738A1 (de)	1989-10-27	1991-05-08	Forssmann Wolf Georg	Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5208041A (en)	1991-05-23	1993-05-04	Allelix Biopharmaceuticals Inc.	Essentially pure human parathyroid hormone
US5556940A (en)	1994-06-20	1996-09-17	National Research Council Of Canada	Parathyroid hormone analogues for the treatment of osteoporosis
JPH0873376A (ja) *	1994-09-07	1996-03-19	Asahi Chem Ind Co Ltd	骨粗鬆症治療薬
US5747456A (en) *	1994-12-19	1998-05-05	Beth Israel Deaconess Medical Center	Continuous low-dose administration of parathyroid hormone or its agonist
WO1996019246A1 (fr) *	1994-12-19	1996-06-27	Beth Israel Hospital Association	Administration en continu de faibles doses d'hormone parathyroïdienne ou de son agoniste
CA2206657C (fr) *	1994-12-22	2009-05-19	Astra Aktiebolag	Preparation therapeutique a inhaler contenant de l'hormone parathyroidienne, hpt
JPH08310965A (ja) *	1995-05-16	1996-11-26	Chugai Pharmaceut Co Ltd	骨癒合促進剤
RU2224539C2 (ru) *	1997-09-09	2004-02-27	Ф.Хоффманн-Ля Рош Аг	Заживление переломов с помощью аналогов пептида, подобного паратироидному гормону (ртнrр)
MY120063A (en)	1997-12-09	2005-08-30	Lilly Co Eli	Stabilized teriparatide solutions
US20040033950A1 (en) *	2000-09-26	2004-02-19	Hock Janet M.	Method of increasing bone toughness and stiffness and reducing fractures
DZ2873A1 (fr)	1998-08-19	2003-12-15	Lilly Co Eli	Procédé pour augmenter la dureté et la rigidité osseuse.
US6907597B1 (en)	2000-10-13	2005-06-14	Ati International Srl	Method and apparatus for constructing an executable program in memory
US6967759B2 (en)	2001-12-31	2005-11-22	Texas Instruments Incorporated	Pulse width modulation sequence generation
JP5796714B2 (ja)	2012-01-13	2015-10-21	株式会社リコー	定着装置及び画像形成装置
EP2949301B1 (fr)	2014-05-27	2018-04-18	The Procter and Gamble Company	Noyau absorbant avec des zones de matériau absorbant incurvées et droites

1999
- 1999-08-18 DZ DZ990173A patent/DZ2873A1/fr active
- 1999-08-18 AR ARP990104133A patent/AR033639A1/es unknown
- 1999-08-19 DK DK99942350T patent/DK1059933T3/da active
- 1999-08-19 DK DK10180447.4T patent/DK2266598T3/en active
- 1999-08-19 AU AU55750/99A patent/AU746277B2/en not_active Expired
- 1999-08-19 ES ES06027055T patent/ES2393200T3/es not_active Expired - Lifetime
- 1999-08-19 EP EP99942350A patent/EP1059933B1/fr not_active Revoked
- 1999-08-19 DK DK15152726.4T patent/DK2907522T3/en active
- 1999-08-19 PT PT99942350T patent/PT1059933E/pt unknown
- 1999-08-19 UA UA2000095457A patent/UA72205C2/uk unknown
- 1999-08-19 EP EP10180447.4A patent/EP2266598B1/fr not_active Expired - Lifetime
- 1999-08-19 CO CO99052525A patent/CO5130020A1/es unknown
- 1999-08-19 DK DK06027055.0T patent/DK1769804T3/da active
- 1999-08-19 AT AT99942350T patent/ATE231000T1/de not_active IP Right Cessation
- 1999-08-19 KR KR10-2001-7002092A patent/KR100454207B1/ko not_active IP Right Cessation
- 1999-08-19 NZ NZ507056A patent/NZ507056A/en not_active IP Right Cessation
- 1999-08-19 PL PL343595A patent/PL201688B1/pl not_active IP Right Cessation
- 1999-08-19 WO PCT/US1999/018961 patent/WO2000010596A1/fr active IP Right Grant
- 1999-08-19 PT PT06027055T patent/PT1769804E/pt unknown
- 1999-08-19 HU HUP1200430 patent/HU1200430D0/hu not_active Application Discontinuation
- 1999-08-19 US US09/647,278 patent/US6977077B1/en not_active Expired - Lifetime
- 1999-08-19 ES ES99942350T patent/ES2190244T3/es not_active Expired - Lifetime
- 1999-08-19 EP EP15152726.4A patent/EP2907522B1/fr not_active Revoked
- 1999-08-19 BR BR9909445-2A patent/BR9909445A/pt not_active Application Discontinuation
- 1999-08-19 PT PT15152726T patent/PT2907522T/pt unknown
- 1999-08-19 CZ CZ20004134A patent/CZ301017B6/cs not_active IP Right Cessation
- 1999-08-19 CA CA002325371A patent/CA2325371C/fr not_active Expired - Lifetime
- 1999-08-19 HU HU0101594A patent/HU230697B1/hu unknown
- 1999-08-19 DE DE69904918T patent/DE69904918T2/de not_active Expired - Lifetime
- 1999-08-19 TR TR2000/03455T patent/TR200003455T2/xx unknown
- 1999-08-19 PT PT101804474T patent/PT2266598T/pt unknown
- 1999-08-19 MY MYPI99003553A patent/MY129227A/en unknown
- 1999-08-19 ES ES10180447.4T patent/ES2621653T3/es not_active Expired - Lifetime
- 1999-08-19 ID IDW20010612A patent/ID29039A/id unknown
- 1999-08-19 IL IL13882999A patent/IL138829A0/xx unknown
- 1999-08-19 JP JP2000565916A patent/JP2002523375A/ja active Pending
- 1999-08-19 CN CNB998083534A patent/CN1205997C/zh not_active Expired - Lifetime
- 1999-08-19 ES ES15152726.4T patent/ES2549551T3/es not_active Expired - Lifetime
- 1999-08-19 EA EA200001015A patent/EA003362B1/ru not_active IP Right Cessation
- 1999-08-19 PE PE1999000839A patent/PE20001089A1/es not_active Application Discontinuation
- 1999-08-19 DE DE15152726.4T patent/DE15152726T1/de active Pending
- 1999-10-26 TW TW088114185A patent/TW576747B/zh not_active IP Right Cessation
2000
- 2000-10-03 IL IL138829A patent/IL138829A/en unknown
- 2000-11-06 HR HR20000755A patent/HRP20000755A2/hr not_active Application Discontinuation
- 2000-11-24 NO NO20005947A patent/NO323984B1/no not_active IP Right Cessation
2001
- 2001-02-14 HK HK01101056A patent/HK1030545A1/xx unknown
2005
- 2005-04-05 US US11/098,894 patent/US7163684B2/en not_active Expired - Lifetime
2007
- 2007-06-11 NO NO20072983A patent/NO20072983L/no not_active Application Discontinuation
- 2007-10-04 HK HK07110798.6A patent/HK1102496A1/xx unknown
2010
- 2010-10-29 JP JP2010244314A patent/JP2011021035A/ja not_active Withdrawn
2012
- 2012-11-14 CY CY20121101096T patent/CY1113343T1/el unknown
2014
- 2014-03-25 JP JP2014061763A patent/JP6177718B2/ja not_active Expired - Lifetime
- 2014-10-03 JP JP2014204577A patent/JP2015028065A/ja not_active Withdrawn
2016
- 2016-01-18 HK HK16100519.4A patent/HK1212602A1/zh not_active IP Right Cessation
2017
- 2017-06-26 JP JP2017124301A patent/JP2017190332A/ja not_active Withdrawn
- 2017-10-13 CY CY20171101077T patent/CY1119552T1/el unknown

Also Published As

Publication number	Publication date
KR20010072763A (ko)	2001-07-31
JP6177718B2 (ja)	2017-08-09
AR033639A1 (es)	2004-01-07
ES2393200T3 (es)	2012-12-19
PT1059933E (pt)	2003-06-30
DZ2873A1 (fr)	2003-12-15
CA2325371A1 (fr)	2000-03-02
DK2907522T1 (da)	2015-10-19
CO5130020A1 (es)	2002-02-27
CZ20004134A3 (cs)	2001-08-15
ES2621653T3 (es)	2017-07-04
JP2017190332A (ja)	2017-10-19
TR200003455T2 (tr)	2001-06-21
DE15152726T1 (de)	2015-12-10
CY1113343T1 (el)	2016-06-22
TW576747B (en)	2004-02-21
DK1059933T3 (da)	2003-04-07
ES2549551T3 (es)	2017-11-27
KR100454207B1 (ko)	2004-10-26
EP2907522B1 (fr)	2017-08-02
NO20072983L (no)	2000-11-24
PE20001089A1 (es)	2000-11-04
IL138829A0 (en)	2001-10-31
HU1200430D0 (hu)	2001-11-28
HUP0101594A2 (hu)	2001-11-28
DK2266598T3 (en)	2017-05-15
AU5575099A (en)	2000-03-14
PL201688B1 (pl)	2009-04-30
CY1119552T1 (el)	2018-03-07
JP2011021035A (ja)	2011-02-03
NZ507056A (en)	2003-10-31
US7163684B2 (en)	2007-01-16
HUP0101594A3 (en)	2002-01-28
NO20005947L (no)	2000-11-24
NO20005947D0 (no)	2000-11-24
PL343595A1 (en)	2001-08-27
US6977077B1 (en)	2005-12-20
UA72205C2 (uk)	2005-02-15
HU230697B1 (hu)	2017-09-28
NO323984B1 (no)	2007-07-30
BR9909445A (pt)	2000-12-12
PT1769804E (pt)	2012-11-13
AU746277B2 (en)	2002-04-18
CN1205997C (zh)	2005-06-15
DK2907522T3 (en)	2017-10-23
EA200001015A1 (ru)	2001-02-26
PT2266598T (pt)	2017-05-02
HRP20000755A2 (en)	2001-02-28
WO2000010596A1 (fr)	2000-03-02
EP1059933A1 (fr)	2000-12-20
EP2907522A1 (fr)	2015-08-19
HK1212602A1 (zh)	2016-06-17
ATE231000T1 (de)	2003-02-15
EP1059933B1 (fr)	2003-01-15
MY129227A (en)	2007-03-30
EA003362B1 (ru)	2003-04-24
CN1308545A (zh)	2001-08-15
JP2015028065A (ja)	2015-02-12
IL138829A (en)	2011-01-31
JP2002523375A (ja)	2002-07-30
ID29039A (id)	2001-07-26
JP2014139220A (ja)	2014-07-31
DK1769804T3 (da)	2012-10-15
EP2266598A1 (fr)	2010-12-29
CA2325371C (fr)	2004-08-17
US20050197294A1 (en)	2005-09-08
CZ301017B6 (cs)	2009-10-14
PT2907522T (pt)	2017-10-23
DE69904918T2 (de)	2003-11-13
DE69904918D1 (de)	2003-02-20
HK1102496A1 (en)	2007-11-23
ES2549551T1 (es)	2015-10-29
ES2190244T3 (es)	2003-07-16
EP2266598B1 (fr)	2017-02-22

Publication	Publication Date	Title
HK1030545A1 (en)	2001-05-11	Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture
AU5799099A (en)	2000-03-21	Method and devices for use in bone fixation procedures
PL339449A1 (en)	2000-12-18	Treatment of bone fractures involving the use of pthrp analogues
ZA9510147B (en)	1997-05-29	Hard tissue bone cements and substitutes
EP0767624A4 (fr)	1998-09-23	Dispositifs et procedes de preparation osseuse/tissulaire
GB2356147B (en)	2004-07-07	Bone alignment and fixation device
EP0791338A3 (fr)	1997-10-29	Attache chirurgicale à utiliser dans la fixation de fractures d'os
AU2002353044A8 (en)	2003-06-17	System and method for bone fixation
IL143645A0 (en)	2002-04-21	Improved device for the external fixation of bone fractures, in particular ankle fractures
PL339548A1 (en)	2000-12-18	Implant for uniting two fragments of fractured bone
EP1028665A4 (fr)	2003-12-03	Structure de renforcement de fracture osseuse et procede correspondant
HUP0004313A3 (en)	2001-04-28	Implant for stabilizing a fracture and screw for use in surgery
AU3745700A (en)	2000-10-09	Fastener and method for bone fixation
IL133864A0 (en)	2001-04-30	Combination distraction dental implant and method of use
HUP0104836A3 (en)	2002-08-28	Bone fixation system
HK1046378A1 (en)	2003-01-10	Bioactive and osteoporotic bone cement
EP1133261A4 (fr)	2005-01-05	Dispositif de fixation helicoidal et applicateur pour actes chirurgicaux
ZA953006B (en)	1997-01-08	Human bone stimulating factor
AU3904200A (en)	2000-11-02	Bone fracture fixation clip
GB9421362D0 (en)	1994-12-07	Orthopaedic human bone demonstational aid
EP0779812A4 (fr)	1997-09-10	Procedes de traitement de l'osteoporose utilisant des phosphonates osteoactifs et une hormone parathiro dienne
PL321836A1 (en)	1997-12-22	Method of reducing the risk of vertebral bone fracture
HUP9904049A3 (en)	2000-07-28	Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosis
EP0691349A3 (fr)	1997-09-10	Proteines dimériques morphogénétiques d'origine osseuse et leur fragments et anologues et compositions pharmaceutiques les contenants
SI1059933T1 (en)	2003-04-30	Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force